INS and Insulin resistance: Therefore, based on animal studies and the traditional use of the internal septum of J.regia to lower hemoglobin A1c (HbA1c), fasting blood sugar (FBS), and insulin resistance, this clinical trial designed to assess the effectiveness of J.regia internal septum containing capsules on HbA1c, FBS, blood insulin level, and insulin resistance.